ExtremoChem Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

ExtremoChem General Information

Description

Operator of a chemical synthesis company intended to focus on the development and commercialization of novel small synthetic molecules for the stabilization of biologicals under stress conditions. The company offers a wide range of services including accelerated stability studies, pH stability assessment, thermal stability assessment, aggregation analysis, synthetic routes research and many more, enabling life science research organizations, pharmaceutical, biotech, agrochemical and chemical industries to stabilize medicines and proteins that are unstable at room temperature to store and stabilize at room temperature.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Edifício Arcis
  • Rua Ivone Silva, 6, 4 degree piso
  • Lisbon, 1050-124
  • Portugal
Primary Industry
Specialty Chemicals
Other Industries
Other Commercial Services
Acquirer
Vertical(s)
Corporate Office
  • Edifício Arcis
  • Rua Ivone Silva, 6, 4 degree piso
  • Lisbon, 1050-124
  • Portugal

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExtremoChem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 16-Nov-2023 Completed Generating Revenue
3. Grant 31-Aug-2017 Completed Generating Revenue
2. Accelerator/Incubator 23-Dec-2013 Completed Generating Revenue
1. University Spin-Out 01-Jan-2013 Completed Startup
To view ExtremoChem’s complete valuation and funding history, request access »

ExtremoChem Patents

ExtremoChem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021502422-A Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecular stabilizers Pending 13-Nov-2017
JP-2026133393-A Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecule stabilizers Pending 13-Nov-2017
JP-7853339-B2 Neutral glycosylated amides and dianionic glucuron-oxidized acids as biomolecule stabilizers Active 13-Nov-2017
CA-3082696-A1 Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules Active 13-Nov-2017
EP-3710463-A1 Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules Pending 13-Nov-2017 C07H15/04
To view ExtremoChem’s complete patent history, request access »

ExtremoChem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExtremoChem Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acelerador de Comercialização de Tecnologias Accelerator/Incubator Minority
Horizon 2020 Government
To view ExtremoChem’s complete investors history, request access »

ExtremoChem FAQs

  • When was ExtremoChem founded?

    ExtremoChem was founded in 2013.

  • Where is ExtremoChem headquartered?

    ExtremoChem is headquartered in Lisbon, Portugal.

  • What is the size of ExtremoChem?

    ExtremoChem has 6 total employees.

  • What industry is ExtremoChem in?

    ExtremoChem’s primary industry is Specialty Chemicals.

  • Is ExtremoChem a private or public company?

    ExtremoChem is a Private company.

  • What is ExtremoChem’s current revenue?

    The current revenue for ExtremoChem is .

  • Who are ExtremoChem’s investors?

    Acelerador de Comercialização de Tecnologias and Horizon 2020 have invested in ExtremoChem.

  • When was ExtremoChem acquired?

    ExtremoChem was acquired on 16-Nov-2023.

  • Who acquired ExtremoChem?

    ExtremoChem was acquired by Hovione.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process